Cerebral cavernous malformation proteins at a glance

Journal of Cell Science

Volumn 127, Issue 4, 2014, Pages 701-707

  Draheim, Kyle M ^a   Fisher, Oriana S ^a   Boggon, Titus J ^a   Calderwood, David A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CCM; Cell signaling; Cerebral cavernous malformations; KRIT1; PCDC10; Rho signaling; Vascular biology

Indexed keywords

CCM; CELL SIGNALING; CEREBRAL CAVERNOUS MALFORMATIONS; KRIT1; PCDC10; RHO SIGNALING; VASCULAR BIOLOGY;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CAPILLARY PERMEABILITY; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM NEOPLASMS; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84894040763     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.138388     Document Type: Article

References (87)

1. Akers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M. and Marchuk, D. A. (2009). Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum. Mol. Genet. 18, 919-930.
2. Béraud-Dufour, S., Gautier, R., Albiges-Rizo, C., Chardin, P. and Faurobert, E. (2007). Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1. FEBS J. 274, 5518-5532.
3. Borikova, A. L., Dibble, C. F., Sciaky, N., Welch, C. M., Abell, A. N., Bencharit, S. and Johnson, G. L. (2010). Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J. Biol. Chem. 285, 11760-11764.
4. Boulday, G., Blécon, A., Petit, N., Chareyre, F., Garcia, L. A., Niwa-Kawakita, M., Giovannini, M. and Tournier-Lasserve, E. (2009). Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Dis. Model. Mech. 2, 168-177.
5. Boulday, G., Rudini, N., Maddaluno, L., Blécon, A., Arnould, M., Gaudric, A., Chapon, F., Adams, R. H., Dejana, E. and Tournier-Lasserve, E. (2011). Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 208, 1835-1847.
6. Cavalcanti, D. D., Kalani, M. Y., Martirosyan, N. L., Eales, J., Spetzler, R. F. and Preul, M. C. (2012). Cerebral cavernous malformations: from genes to proteins to disease. J. Neurosurg. 116, 122-132.
7. Chan, A. C., Drakos, S. G., Ruiz, O. E., Smith, A. C., Gibson, C. C., Ling, J., Passi, S. F., Stratman, A. N., Sacharidou, A., Revelo, M. P. et al. (2011). Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J. Clin. Invest. 121, 1871-1881.
8. Chen, L., Tanriover, G., Yano, H., Friedlander, R., Louvi, A. and Gunel, M. (2009). Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3. Stroke 40, 1474-1481.
9. Costa, B., Kean, M. J., Ast, V., Knight, J. D., Mett, A., Levy, Z., Ceccarelli, D. F., Badillo, B. G., Eils, R., Kö nig, R. et al. (2012). STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin. J. Biol. Chem. 287, 29285-29289.
10. Crose, L. E., Hilder, T. L., Sciaky, N. and Johnson, G. L. (2009). Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J. Biol. Chem. 284, 13301-13305.
11. Cunningham, K., Uchida, Y., O'Donnell, E., Claudio, E., Li, W., Soneji, K., Wang, H., Mukouyama, Y. S. and Siebenlist, U. (2011). Conditional deletion of Ccm2 causes hemorrhage in the adult brain: a mouse model of human cerebral cavernous malformations. Hum. Mol. Genet. 20, 3198-3206.
12. Dammann, P., Hehr, U., Weidensee, S., Zhu, Y., Gerlach, R. and Sure, U. (2013). Two-hit mechanism in cerebral cavernous malformation? A case of monozygotic twins with a CCM1/KRIT1 germline mutation. Neurosurg. Rev. 36, 483-486.
13. Denier, C., Labauge, P., Bergametti, F., Marchelli, F., Riant, F., Arnoult, M., Maciazek, J., Vicaut, E., Brunereau, L., Tournier-Lasserve, E.; Socié té Française de Neurochirurgie (2006). Genotype-phenotype correlations in cerebral cavernous malformations patients. Ann. Neurol. 60, 550-556.
14. Dibble, C. F., Horst, J. A., Malone, M. H., Park, K., Temple, B., Cheeseman, H., Barbaro, J. R., Johnson, G. L. and Bencharit, S. (2010). Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate. PLoS ONE 5, e11740.
15. Ding, J., Wang, X., Li, D. F., Hu, Y., Zhang, Y. and Wang, D. C. (2010). Crystal structure of human programmed cell death 10 complexed with inositol-(1,3,4,5)-tetrakisphosphate: a novel adaptor protein involved in human cerebral cavernous malformation. Biochem. Biophys. Res. Commun. 399, 587-592.
16. Faurobert, E. and Albiges-Rizo, C. (2010). Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 277, 1084-1096.
17. Faurobert, E., Rome, C., Lisowska, J., Manet-Dupé , S., Boulday, G., Malbouyres, M., Balland, M., Bouin, A. P., Kéramidas, M., Bouvard, D. et al. (2013). CCM1-ICAP-1 complex controls b1 integrin-dependent endothelial contractility and fibronectin remodeling. J. Cell Biol. 202, 545-561.
18. Fidalgo, M., Fraile, M., Pires, A., Force, T., Pombo, C. and Zalvide, J. (2010). CCM3/PDCD10 stabilizes GCKIII proteins to promote Golgi assembly and cell orientation. J. Cell Sci. 123, 1274-1284.
19. Fidalgo, M., Guerrero, A., Fraile, M., Iglesias, C., Pombo, C. M. and Zalvide, J. (2012). Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress. J. Biol. Chem. 287, 11556-11565.
20. Fischer, A., Zalvide, J., Faurobert, E., Albiges-Rizo, C. and Tournier-Lasserve, E. (2013). Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol. Med. 19, 302-308.
21. Fisher, O. S., Zhang, R., Li, X., Murphy, J. W., Demeler, B. and Boggon, T. J. (2013). Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus. FEBS Lett. 587, 272-277.
22. Francalanci, F., Avolio, M., De Luca, E., Longo, D., Menchise, V., Guazzi, P., Sgrò , F., Marino, M., Goitre, L., Balzac, F. et al. (2009). Structural and functional differences between KRIT1A and KRIT1B isoforms: a framework for understanding CCM pathogenesis. Exp. Cell Res. 315, 285-303.
23. Gingras, A. R., Liu, J. J. and Ginsberg, M. H. (2012). Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. J. Cell Biol. 199, 39-48.
24. Gingras, A. R., Puzon-McLaughlin, W. and Ginsberg, M. H. (2013). The structure of the ternary complex of Krev Interaction Trapped 1 (KRIT1) bound to both the Rap1 GTPase and the heart of Glass (HEG1) cytoplasmic tail. J. Biol. Chem. 288, 23639-23649.
25. Glading, A. J. and Ginsberg, M. H. (2010). Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis. Model. Mech. 3, 73-83.
26. Glading, A., Han, J., Stockton, R. A. and Ginsberg, M. H. (2007). KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J. Cell Biol. 179, 247-254.
27. Goitre, L., Balzac, F., Degani, S., Degan, P., Marchi, S., Pinton, P. and Retta, S. F. (2010). KRIT1 regulates the homeostasis of intracellular reactive oxygen species. PLoS ONE 5, e11786.
28. Gore, A. V., Lampugnani, M. G., Dye, L., Dejana, E. and Weinstein, B. M. (2008). Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis. Model. Mech. 1, 275-281.
29. Goudreault, M., D'Ambrosio, L. M., Kean, M. J., Mullin, M. J., Larsen, B. G., Sanchez, A., Chaudhry, S., Chen, G. I., Sicheri, F., Nesvizhskii, A. I. et al. (2009). A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Mol. Cell. Proteomics 8, 157-171.
30. Guazzi, P., Goitre, L., Ferro, E., Cutano, V., Martino, C., Trabalzini, L. and Retta, S. F. (2012). Identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1. PLoS ONE 7, e44705.
31. Guzeloglu-Kayisli, O., Amankulor, N. M., Voorhees, J., Luleci, G., Lifton, R. P. and Gunel, M. (2004). KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex. Neurosurgery 54, 943-949, discussion 949.
32. Harel, L., Costa, B., Tcherpakov, M., Zapatka, M., Oberthuer, A., Hansford, L. M., Vojvodic, M., Levy, Z., Chen, Z. Y., Lee, F. S. et al. (2009). CCM2 mediates death signaling by the TrkA receptor tyrosine kinase. Neuron 63, 585-591.
33. He, Y., Zhang, H., Yu, L., Gunel, M., Boggon, T. J., Chen, H. and Min, W. (2010). Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci. Signal. 3, ra26.
34. Hilder, T. L., Malone, M. H., Bencharit, S., Colicelli, J., Haystead, T. A., Johnson, G. L. and Wu, C. C. (2007a). Proteomic identification of the cerebral cavernous malformation signaling complex. J. Proteome Res. 6, 4343-4355.
35. Hilder, T. L., Malone, M. H. and Johnson, G. L. (2007b). Hyperosmotic induction of mitogen-activated protein kinase scaffolding. Methods Enzymol. 428, 297-312.
36. Hogan, B. M., Bussmann, J., Wolburg, H. and Schulte-Merker, S. (2008). ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum. Mol. Genet. 17, 2424-2432.
37. Kean, M. J., Ceccarelli, D. F., Goudreault, M., Sanches, M., Tate, S., Larsen, B., Gibson, L. C., Derry, W. B., Scott, I. C., Pelletier, L. et al. (2011). Structurefunction analysis of core STRIPAK proteins: a signaling complex implicated in Golgi polarization. J. Biol. Chem. 286, 25065-25075.
38. Kleaveland, B., Zheng, X., Liu, J. J., Blum, Y., Tung, J. J., Zou, Z., Sweeney, S. M., Chen, M., Guo, L., Lu, M. M. et al. (2009). Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat. Med. 15, 169-176.
39. Lampugnani, M. G., Orsenigo, F., Rudini, N., Maddaluno, L., Boulday, G., Chapon, F. and Dejana, E. (2010). CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J. Cell Sci. 123, 1073-1080.
40. Li, D. Y. and Whitehead, K. J. (2010). Evaluating strategies for the treatment of cerebral cavernous malformations. Stroke 41 Suppl., S92-S94.
41. Li, X., Zhang, R., Zhang, H., He, Y., Ji, W., Min, W. and Boggon, T. J. (2010). Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity. J. Biol. Chem. 285, 24099-24107.
42. Li, X., Ji, W., Zhang, R., Folta-Stogniew, E., Min, W. and Boggon, T. J. (2011). Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3). J. Biol. Chem. 286, 26138-26147.
43. Li, X., Zhang, R., Draheim, K. M., Liu, W., Calderwood, D. A. and Boggon, T. J. (2012). Structural basis for small G protein effector interaction of Ras-related protein 1 (Rap1) and adaptor protein Krev interaction trapped 1 (KRIT1). J. Biol. Chem. 287, 22317-22327.
44. Limaye, N., Boon, L. M. and Vikkula, M. (2009). From germline towards somatic mutations in the pathophysiology of vascular anomalies. Hum. Mol. Genet. 18 R1, R65-R74.
45. Lin, C., Meng, S., Zhu, T. and Wang, X. (2010). PDCD10/CCM3 acts downstream of gamma-protocadherins to regulate neuronal survival. J. Biol. Chem. 285, 41675-41685.
46. Liquori, C. L., Berg, M. J., Siegel, A. M., Huang, E., Zawistowski, J. S., Stoffer, T., Verlaan, D., Balogun, F., Hughes, L., Leedom, T. P. et al. (2003). Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am. J. Hum. Genet. 73, 1459-1464.
47. Liu, J. J., Stockton, R. A., Gingras, A. R., Ablooglu, A. J., Han, J., Bobkov, A. A. and Ginsberg, M. H. (2011). A mechanism of Rap1-induced stabilization of endothelial cell-cell junctions. Mol. Biol. Cell 22, 2509-2519.
48. Liu, W., Draheim, K. M., Zhang, R., Calderwood, D. A. and Boggon, T. J. (2013). Mechanism for KRIT1 release of ICAP1-mediated suppression of integrin activation. Mol. Cell 49, 719-729.
49. Louvi, A., Chen, L., Two, A. M., Zhang, H., Min, W. and Gü nel, M. (2011). Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology. Proc. Natl. Acad. Sci. USA 108, 3737-3742.
50. Mably, J. D., Mohideen, M. A., Burns, C. G., Chen, J. N. and Fishman, M. C. (2003). heart of glass regulates the concentric growth of the heart in zebrafish. Curr. Biol. 13, 2138-2147.
51. Mably, J. D., Chuang, L. P., Serluca, F. C., Mohideen, M. A., Chen, J. N. and Fishman, M. C. (2006). santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133, 3139-3146.
52. Maddaluno, L., Rudini, N., Cuttano, R., Bravi, L., Giampietro, C., Corada, M., Ferrarini, L., Orsenigo, F., Papa, E., Boulday, G. et al. (2013). EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496.
53. McDonald, D. A., Shenkar, R., Shi, C., Stockton, R. A., Akers, A. L., Kucherlapati, M. H., Kucherlapati, R., Brainer, J., Ginsberg, M. H., Awad, I. A. et al. (2011). A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum. Mol. Genet. 20, 211-222.
54. McDonald, D. A., Shi, C., Shenkar, R., Stockton, R. A., Liu, F., Ginsberg, M. H., Marchuk, D. A. and Awad, I. A. (2012). Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 43, 571-574.
55. Millon-Fré millon, A., Bouvard, D., Grichine, A., Manet-Dupé , S., Block, M. R. and Albiges-Rizo, C. (2008). Cell adaptive response to extracellular matrix density is controlled by ICAP-1-dependent beta1-integrin affinity. J. Cell Biol. 180, 427-441.
56. Pagenstecher, A., Stahl, S., Sure, U. and Felbor, U. (2009). A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum. Mol. Genet. 18, 911-918.
57. Petit, N., Blécon, A., Denier, C. and Tournier-Lasserve, E. (2006). Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development. Gene Expr. Patterns 6, 495-503.
58. Plummer, N. W., Gallione, C. J., Srinivasan, S., Zawistowski, J. S., Louis, D. N. and Marchuk, D. A. (2004). Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. Am. J. Pathol. 165, 1509-1518.
59. Plummer, N. W., Squire, T. L., Srinivasan, S., Huang, E., Zawistowski, J. S., Matsunami, H., Hale, L. P. and Marchuk, D. A. (2006). Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations. Mamm. Genome 17, 119-128.
60. Riant, F., Cecillon, M., Saugier-Veber, P. and Tournier-Lasserve, E. (2013). CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics 14, 133-141.
61. Rosen, J. N., Sogah, V. M., Ye, L. Y. and Mably, J. D. (2013). ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway. Dev. Biol. 376, 74-85.
62. Schneider, H., Errede,M., Ulrich, N. H., Virgintino, D., Frei, K. and Bertalanffy, H. (2011). Impairment of tight junctions and glucose transport in endothelial cells of human cerebral cavernousmalformations. J.Neuropathol.Exp.Neurol. 70, 417-429.
63. Seker, A., Pricola, K. L., Guclu, B., Ozturk, A. K., Louvi, A. and Gunel, M. (2006). CCM2 expression parallels that of CCM1. Stroke 37, 518-523.
64. Serebriiskii, I., Estojak, J., Sonoda, G., Testa, J. R. and Golemis, E. A. (1997). Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15, 1043-1049.
65. Stahl, S., Gaetzner, S., Voss, K., Brackertz, B., Schleider, E., Sü rü cü , O., Kunze, E., Netzer, C., Korenke, C., Finckh, U. et al. (2008). Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex. Hum. Mutat. 29, 709-717.
66. Stockton, R. A., Shenkar, R., Awad, I. A. and Ginsberg, M. H. (2010). Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J. Exp. Med. 207, 881-896.
67. Sugden, P. H., McGuffin, L. J. and Clerk, A. (2013). SOcK, MiSTs, MASK and STicKs: the GCKIII (germinal centre kinase III) kinases and their heterologous protein-protein interactions. Biochem. J. 454, 13-30.
68. Tanriover, G., Sozen, B., Seker, A., Kilic, T., Gunel, M. and Demir, N. (2013). Ultrastructural analysis of vascular features in cerebral cavernous malformations. Clin. Neurol. Neurosurg. 115, 438-444.
69. Uhlik, M. T., Abell, A. N., Johnson, N. L., Sun, W., Cuevas, B. D., Lobel-Rice, K. E., Horne, E. A., Dell'Acqua, M. L. and Johnson, G. L. (2003). Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat. Cell Biol. 5, 1104-1110.
70. Voss, K., Stahl, S., Schleider, E., Ullrich, S., Nickel, J., Mueller, T. D. and Felbor, U. (2007). CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations. Neurogenetics 8, 249-256.
71. Voss, K., Stahl, S., Hogan, B. M., Reinders, J., Schleider, E., Schulte-Merker, S. and Felbor, U. (2009). Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum. Mutat. 30, 1003-1011.
72. Wang, Y., Liu, H., Zhang, Y. and Ma, D. (1999). cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene. Sci. China C Life Sci. 42, 323-329.
73. Whitehead, K. J., Plummer, N. W., Adams, J. A., Marchuk, D. A. and Li, D. Y. (2004). Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131, 1437-1448.
74. Whitehead, K. J., Chan, A. C., Navankasattusas, S., Koh, W., London, N. R., Ling, J., Mayo, A. H., Drakos, S. G., Jones, C. A., Zhu, W. et al. (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat. Med. 15, 177-184.
75. Wü stehube, J., Bartol, A., Liebler, S. S., Brü tsch, R., Zhu, Y., Felbor, U., Sure, U., Augustin, H. G. and Fischer, A. (2010). Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proc. Natl. Acad. Sci. USA 107, 12640-12645.
76. Xu, X., Wang, X., Zhang, Y., Wang, D. C. and Ding, J. (2013). Structural basis for the unique heterodimeric assembly between cerebral cavernous malformation 3 and germinal center kinase III. Structure 21, 1059-1066.
77. Yoruk, B., Gillers, B. S., Chi, N. C. and Scott, I. C. (2012). Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease. Dev. Biol. 362, 121-131.
78. You, C., Sandalcioglu, I. E., Dammann, P., Felbor, U., Sure, U. and Zhu, Y. (2013). Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. J. Cell. Mol. Med. 17, 407-418.
79. Zawistowski, J. S., Stalheim, L., Uhlik, M. T., Abell, A. N., Ancrile, B. B., Johnson, G. L. and Marchuk, D. A. (2005). CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum. Mol. Genet. 14, 2521-2531.
80. Zhang, J., Rigamonti, D., Dietz, H. C. and Clatterbuck, R. E. (2007). Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations. Neurosurgery 60, 353-359, discussion 359.
81. Zhang, M., Dong, L., Shi, Z., Jiao, S., Zhang, Z., Zhang,W., Liu, G., Chen, C., Feng, M., Hao, Q. et al. (2013a). Structural mechanism of CCM3 heterodimerization with GCKIII kinases. Structure 21, 680-688.
82. Zhang, Y., Tang, W., Zhang, H., Niu, X., Xu, Y., Zhang, J., Gao, K., Pan, W., Boggon, T. J., Toomre, D. et al. (2013b). A Network of Interactions Enables CCM3 and STK24 to Coordinate UNC13D-Driven Vesicle Exocytosis in Neutrophils. Dev. Cell 27, 215-226.
83. Zheng, X., Xu, C., Di Lorenzo, A., Kleaveland, B., Zou, Z., Seiler, C., Chen, M., Cheng, L., Xiao, J., He, J. et al. (2010). CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J. Clin. Invest. 120, 2795-2804.
84. Zheng, X., Xu, C., Smith, A. O., Stratman, A. N., Zou, Z., Kleaveland, B., Yuan, L., Didiku, C., Sen, A., Liu, X. et al. (2012). Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth. Dev. Cell 23, 342-355.
85. Zhou, X., Izumi, Y., Burg, M. B. and Ferraris, J. D. (2011). Rac1/osmosensing scaffold for MEKK3 contributes via phospholipase C-gamma1 to activation of the osmoprotective transcription factor NFAT5. Proc. Natl. Acad. Sci. USA 108, 12155-12160.
86. Zhu, Y., Wu, Q., Xu, J. F., Miller, D., Sandalcioglu, I. E., Zhang, J. M. and Sure, U. (2010). Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations. Neurosurg. Focus 29, E1.
87. Zhu, Y., Wu, Q., Fass, M., Xu, J. F., You, C., Mü ller, O., Sandalcioglu, I. E., Zhang, J. M. and Sure, U. (2011). In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations. Neurosurgery 69, 722-731, discussion 731-732.